A Prospective Outcome Study in Patients With Moderate to Severe Traumatic Brain Injury
NCT ID: NCT03810222
Last Updated: 2021-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
225 participants
OBSERVATIONAL
2017-01-18
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Many patients rescued by ICU treatment may have been severely disabled or vegetative because of trauma. These data suggest that, despite improvement in medical and surgical treatments, other factors related to trauma itself and to patient's condition could have an impact on the final outcome.
Aim of the TBI-PRO project is to collect high quality clinical and epidemiological data and to describe the outcome of moderate-to-severe TBI in a local contest (Bergamo area, Italy).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictors of Better Outcomes After Severe Acquired Brain Injuries
NCT04495192
Long-term Follow-up in Severe Traumatic Brain Injury
NCT05235802
Treatment and Outcome of Patients With Mild Head Injury
NCT07339319
Developing and Validating Blood and Imaging BIOmarkers of AXonal Injury Following Traumatic Brain Injury
NCT03534154
Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study)
NCT04318665
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N/A (Observational Study)
This is an observational study and does not include interventions. Exposure is TBI.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of moderate-to-severe TBI
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PAOLO GRITTI, MD
Role: PRINCIPAL_INVESTIGATOR
ASST- Papa Giovanni XXIII
FRANCESCO BIROLI, MD
Role: STUDY_CHAIR
Fondazione per la Ricerca Ospedale di Bergamo (FROM)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASST- Papa Giovanni XXIII
Bergamo, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TBI-PRO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.